# Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease

> **NCT01168596** · PHASE4 · COMPLETED · sponsor: **University of Florida** · enrollment: 30 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Rasagiline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01168596
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01168596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01168596, "Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01168596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*